Trial Site Detail
Drug: |
BIIB022 |
|||
|---|---|---|---|---|
Trial: |
Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
University of Colorado1665 N. Ursula St. |
Principal Investigator: |
Stephen Leong |
|---|---|
Contact: |
Sarah Eppers 720-848-0052 SARAH.EPPERS@ucdenver.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
University of Colorado Website: |
http://www.uch.edu/conditions/cancer/index1.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.